Adtec Healthcare

Adtec Healthcare is a UK-based medical device company focused on infection management and wound care using cold plasma technology. Its lead commercial product, SteriPlas, is a premium cold plasma device designed to penetrate biofilm, reduce bacterial load, destroy resistant bacteria, and support healing in chronic wounds and related infections. The company positions its technology as a non-antibiotic, non-contact approach for hospitals and clinical settings, with documented clinical use in Europe and growing international ambitions. In 2025, Adtec announced MDR certification for SteriPlas and a $12 million financing led by AIPO Fund with participation from SG Biomedical to support manufacturing scale-up, next-generation device development, and U.S. regulatory expansion.